Pharmaceutical Manufacturing Equipment Market worth $30.39 billion by 2032
The report "Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Filling, Spray Drying, Mixing & Blending, Milling, Tablet Compression, Inspection, Granulation, Sterilization), End Product (Solid, Liquid), Technology - Global Forecast to 2032", The global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 and USD 30.39 billion by 2032, exhibiting a CAGR of 6.2% during the forecast period. The market is expanding due to the rising production of branded generic biologic drugs. The growing prevalence of chronic disease is increasing drug output requirements. Additionally, expanding healthcare access supports higher production volumes. Regulatory compliance remains a key requirement across facilities. Demand for sterile injectables and vaccines is rising, while continuous manufacturing technologies are gaining adoption. Manufacturers integrate automation to improve efficiency. Regulatory standards encouraging equipment modernization and research investment increase the use of high-potency medicines, driving the market.
Browse 165 market data Tables and 75 Figures spread through 255 Pages and in-depth TOC on "Pharmaceutical Manufacturing Equipment Market by Equipment Type (Packaging, Filling, Spray Drying, Mixing & Blending, Milling, Tablet Compression, Inspection, Granulation, Sterilization), End Product (Solid, Liquid), Technology - Global Forecast to 2032"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-manufacturing-equipment-market-268102519.html
“Packaging machines segment is expected to register a significant growth rate between 2026 and 2032”
The packaging machines segment is likely to dominate the pharmaceutical manufacturing equipment market during the forecast period, due to its role in ensuring product safety and regulatory compliance. Packaging represents the final stage of production and directly affects product integrity and labelling accuracy. Shelf life and patient safety depend on secure packaging systems. Strict serialization and tamper-evident requirements increase investment in advanced solutions. Track and trace systems drive the integration of automated packaging lines. Packaging demand is strengthened by the requirement for manufacturers’ compliance with global anti-counterfeiting regulations, as well as the growing production of tablets and capsules. The segmental growth is further driven by the need for high-speed precision systems and the expansion of generic drug manufacturing. Furthermore, the need for compliant packaging systems due to rising exports and contract manufacturing growth drives the segment.
“Solid end-product type captured the largest share of the global pharmaceutical manufacturing equipment market in 2025”
The solid end-product type is expected to dominate the global pharmaceutical manufacturing equipment market during the forecast period due to the high production volume of tablets, capsules, and powders. Solid dosage forms offer longer shelf life and easier storage. Pharmaceutical companies invest in granulation systems and tablet compression presses. Coating machines and capsule filling systems maintain batch consistency and regulatory compliance. The rising prevalence of chronic diseases increases the demand for oral medicines, while the growth in generic drug production strengthens solid formulation output. Contract manufacturing expansion also supports equipment demand. Increasing consumption of oral medications across developed and emerging markets is supporting the growth of the solid dosage segment. Drug manufacturers focus on high-speed tableting and capsule production lines to improve output and reduce operational costs.
“Germany is expected to grow at the highest CAGR in the European pharmaceutical manufacturing equipment market during the forecast period”
Germany is expected to grow at the fastest CAGR in the European pharmaceutical manufacturing equipment market during the forecast period due to its strong pharmaceutical production ecosystem. Continuous investment in advanced manufacturing technologies is driving equipment upgrades. Leadership in automation and precision engineering supports high-performance systems. Adoption of Industry 4.0 enables connected production environments. Expansion of biologics and vaccine manufacturing increases the demand for aseptic processing. Fill finish and containment systems are gaining importance. Capacity expansion by pharmaceutical companies supports equipment investment. CDMOs are upgrading facilities to meet global standards. Stringent regulatory requirements drive the modernization of production lines. These factors support sustained demand for compliant and technologically advanced manufacturing equipment in the country.
Key Players
Leading players in the global pharmaceutical manufacturing equipment market include GEA Group Aktiengesellschaft (Germany), IMA Industria Macchine Automatiche S.p.A (Italy), Syntegon Technology GmbH (Germany), ACG (India), Thermo Fisher Scientific Inc (US), Körber AG (Germany), Coperion GmbH (Germany), Romaco Group (Germany), Marchesini Group S.p.A (Italy), and Bausch+Ströbel SE + Co. KG (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Manufacturing Equipment Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
